Thoracic radiation therapy in limited stage small-cell lung cancer: timing is everything...isn't it?

J Clin Oncol. 2006 Aug 20;24(24):3815-6. doi: 10.1200/JCO.2006.07.2827.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Small Cell / drug therapy
  • Carcinoma, Small Cell / pathology
  • Carcinoma, Small Cell / radiotherapy*
  • Chemotherapy, Adjuvant
  • Cisplatin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Dose Fractionation, Radiation
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Humans
  • London
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology
  • Lung Neoplasms / radiotherapy*
  • Meta-Analysis as Topic
  • Multicenter Studies as Topic
  • Neoplasm Staging
  • Radiotherapy, Adjuvant / methods
  • Randomized Controlled Trials as Topic
  • Survival Analysis
  • Time Factors
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin

Supplementary concepts

  • CAV protocol
  • VP-P protocol